Catalog

Clinical Dialogues are video-based moderated discussions featuring leading experts providing the latest patient management guidelines. eCase Challenges are interactive text or or video-based cases where PAs are presented with challenging case scenarios a

Join PA co-hosts Martine Altieri, Kim Ketchersid, and Joe Harrison as they discuss current topics in JAAPA CME podcast episodes.

JAAPA CME post-tests are available in AAPA's monthly clinical journal or online.

Selecting the appropriate medications to manage type 2 diabetes presents unique challenges. Further, the need to optimize medication dosing increases the management complexities. Through case studies, this session will review dosing strategies for oral antihyperglycemic agents, injectable GLP-1 receptor agonists, and insulin therapies. Participants should complete this session with increased confidence in the nuanced management of medication dosing for their patients with diabetes.

This introductory and comprehensive online certificate program will explore diabetes technology, including continuous glucose monitoring (CGM), remote glucose monitoring, insulin pumps, and connected insulin pens. Participants will learn best practices for utilizing these technologies and the data generated by each to monitor glucose levels, administer insulin, conduct successful patient visits, and make informed decisions to manage and improve patient outcomes with diabetes.

This activity aims to equip participants with the skills to analyze screening recommendations and diagnostic criteria for depression, recognize treatment options for depression, anxiety, and bipolar disorder. The session will provide insight on how to identify and evaluate generalized anxiety and panic disorders. The session covers the prevalence and economic impact of depression, screening and diagnostic tools, risk factors, symptoms, and various treatment options, including pharmacotherapy and psychotherapy.

This evidence-based presentation will provide a detailed discussion on rates of breast, cervical, and colon cancer and a review of screening guidelines. The faculty will apply case-based learning to promote and engage education on how to screen and when to refer. Epidemiology, risk factors, etiology, prevention, and patient education will be summarized.

Evidence-based Treatment Approaches for Adolescent Electronic Cigarette Use | Cerebral Palsy: Current Concepts and a Glimpse Into the Future

In older adults, pneumococcal pneumonia continues to be a leading cause of death. The incidence of pneumonia and related mortality are highest in adults ≥65 years of age and patients with comorbidities, with pneumococci remaining the leading cause of bacteria infection. More concerning is the effect pneumococcal infections can have when they breach the lungs and become invasive. Pneumococcal meningitis is the most frequent and severe suppurative complication associated with pneumococcal bacteremia. Even with appropriate antimicrobial treatment, pneumococcal meningitis has a mortality rate of 20 to 30 percent. Luckily, the increased rates of vaccination and serotypes covered by various vaccines have caused significant reductions in the incidence of invasive pneumococcal disease (IPD). Clinicians treating those at risk of pneumococcal pneumonia and IPD require focused education on the impact of pneumococcal pneumonia and IPD, the importance of serotypes in pneumococcal disease and IPD, guideline updates, and information on recent approvals and evidence.

In older adults, pneumococcal pneumonia continues to be a leading cause of death. The incidence of pneumonia and related mortality are highest in adults ≥65 years of age and patients with comorbidities, with pneumococci remaining the leading cause of bacteria infection. More concerning is the effect pneumococcal infections can have when they breach the lungs and become invasive. Pneumococcal meningitis is the most frequent and severe suppurative complication associated with pneumococcal bacteremia. Even with appropriate antimicrobial treatment, pneumococcal meningitis has a mortality rate of 20 to 30 percent. Luckily, the increased rates of vaccination and serotypes covered by various vaccines have caused significant reductions in the incidence of invasive pneumococcal disease (IPD). Clinicians treating those at risk of pneumococcal pneumonia and IPD require focused education on the impact of pneumococcal pneumonia and IPD, the importance of serotypes in pneumococcal disease and IPD, guideline updates, and information on recent approvals and evidence.